Platinum Investment Management LTD Alector, Inc. Transaction History

Platinum Investment Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$6.88 - $9.55 $246,641 - $342,357	35,849 Added 24.58%	181,689 $1.68 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $329,450 - $530,983	40,226 Added 38.09%	145,840 $1.38 Million
Q1 2022 May 13, 2022	BUY	$13.02 - $20.78 $523,846 - $836,062	40,234 Added 61.54%	105,614 $1.51 Million
Q3 2021 Nov 09, 2021	SELL	$21.65 - $39.49 $314,011 - $572,762	-14,504 Reduced 18.16%	65,380 $1.49 Million
Q2 2021 Aug 11, 2021	BUY	$15.5 - $22.48 $366,482 - $531,517	23,644 Added 42.04%	79,884 $1.66 Million
Q1 2020 May 15, 2020	SELL	$16.25 - $35.28 $596,261 - $1.29 Million	-36,693 Reduced 39.48%	56,240 $1.36 Million
Q3 2019 Nov 14, 2019	SELL	$14.42 - $22.2 $402,692 - $619,957	-27,926 Reduced 23.11%	92,933 $1.34 Million
Q2 2019 Aug 14, 2019	SELL	$16.26 - $26.42 $174,290 - $283,195	-10,719 Reduced 8.15%	120,859 $2.3 Million
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $2.1 Million - $2.96 Million	131,578 New	131,578 $2.46 Million

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $153M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.